NIH-funded research R01 grant

Speaking two languages and brain health in aging and Alzheimer's

Official title: The Role of Bilingualism in Cognitive and Brain Resilience: Addressing the Complexity

Funded at University of California, San Francisco · NIH-11472064 · Data updated 2026-11-12

This project will look at whether speaking two or more languages helps protect thinking skills and brain structure in older adults, including people with Alzheimer’s disease.

More Resilience research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startApril 15, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$78,970
NIH project number3R01AG080396-04S1
Project IDNIH-11472064 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are older adults, both monolingual and bilingual, including those with or at risk for Alzheimer's, who can complete cognitive testing and brain imaging.

Less likely to help

People seeking an immediate treatment or cure, those unable to undergo testing like MRI, or those with very advanced dementia may not receive direct benefit from participation.

What this research studies

You'll be part of a long-term group of older adults where researchers compare people who speak one language and people who speak two or more languages. They will use memory and thinking tests, brain scans, and Alzheimer's biological markers to see whether bilingual speakers have less brain pathology or keep thinking skills better despite pathology. The team will also look at different kinds of thinking tasks, cultural and language background, and types of Alzheimer's to understand when bilingualism helps most. The work uses an existing, well-characterized cohort followed over time at UCSF.

Why it matters

Potential benefit: If successful, the findings could support preserving or promoting bilingualism as a low-cost way to delay cognitive decline or help tailor care for people at risk of Alzheimer's.

How similar studies have gone: Previous studies have shown mixed results—some report delayed symptoms in bilinguals while others find little effect—so this project aims to clarify those inconsistencies.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Deleon, Jessica Anne — University of California, San Francisco
  • Study coordinator: Deleon, Jessica Anne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.